Migraine and cardiovascular disease: A population-based study

Neurology

Volumn 74, Issue 8, 2010, Pages 628-635

  Bigal, M E ^a,b   Kurth, T ^d   Santanello, N ^a   Buse, D ^b   Golden, W ^a   Robbins, M ^b   Lipton, R B ^b,c,e  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Department of Neurology ^*  (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLAUDICATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE AURA; PRIORITY JOURNAL; SELF REPORT; STROKE; STRUCTURED QUESTIONNAIRE;

EID: 77649123795     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d0cc8b     Document Type: Article

References (38)

1. Elliott D. Migraine and stroke: current perspectives. Neurol Res 2008;30:801-812.
2. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
3. Kurth T, Slomke MA, Kase CS, et al. Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 2005;64:1020-1026. (Pubitemid 40388455)
4. MacClellan LR, Mitchell BD, Cole JW, et al. Familial aggregation of ischemic stroke in young women: the Stroke Prevention in Young Women Study. Genet Epidemiol 2006;30:602-608.
5. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006;37:1109-1112.
6. Kurth T, Diener HC. Current views of the risk of stroke for migraine with and migraine without aura. Curr Pain Headache Rep 2006;10:214-220.
7. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-291.
8. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in men. Arch Intern Med 2007; 167:795-801. (Pubitemid 46658337)
9. Rose KM, Carson AP, Sanford CP, et al. Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology 2004;63:2233-2239.
10. Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR. Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology 2007;68:1694-1700. (Pubitemid 46763257)
11. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-620.
12. Scher AI, Terwindt GM, Verschuren WM, et al. Migraine and MTHFR C677T genotype in a population-based sample. Ann Neurol 2006;59:372-375.
13. Schürks M, Zee RY, Buring JE, Kurth T. Polymorphisms in the renin-angiotensin system and migraine in women. Headache 2009;49:292-299.
14. Schürks M, Zee RY, Buring JE, Kurth T. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 2008;71: 505-513.
15. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-349.
16. Stewart WF RM, Bigal ME, Lipton RB. Lifetime migraine incidence: results from the American Migraine Prevalence and Prevention study. Headache 2005;46:52.
17. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study. Headache 2007;47:355-363.
18. Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology 2008;71: 1821-1828.
19. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-657.
20. The International Classification of Headache Disorders, 2nd edition. Cephalalgia 2004;24(suppl 1):1-149.
21. Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008;71:559-566.
22. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Fra-mingham Heart Study. Circulation 2008;117:743-753.
23. Lloyd-Jones DM, Wilson PW, Larson MG, et al. Fra-mingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 2004;94:20-24.
24. Gramling R, Klein W, Roberts M, Waring ME, Gramling D, Eaton CB. Self-rated cardiovascular risk and 15-year cardiovascular mortality. Ann Fam Med 2008;6:302-306.
25. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of isch-aemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
26. Buring JE, Hebert P, Romero J, et al. Migraine and subsequent risk of stroke in the Physicians' Health Study. Arch Neurol 1995;52:129-134.
27. Diener HC, Kurth T. Is migraine a risk factor for stroke? Neurology 2005;64:1496-1497.
28. Porter A, Gladstone JP, Dodick DW. Migraine and white matter hyperintensities. Curr Pain Headache Rep 2005;9: 289-293.
29. Rosamond W. Are migraine and coronary heart disease associated? An epidemiologic review. Headache 2004;44 suppl 1:S5-S12.
30. Wayne VS. A possible relationship between migraine and coronary artery spasm. Aust NZ J Med 1986;16:708-710.
31. Uyarel H, Erden I, Cam N. Acute migraine attack, anginalike chest pain with documented ST-segment elevation and slow coronary flow. Acta Cardiol 2005;60:221-223.
32. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009;72:1864-1871.
33. Bigal M, Kurth T, Hu H, Santanello N, Lipton R. Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 2009;72:1864-1871.
34. Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 2006;113:1578-1587.
35. Hargreaves RJ. Pharmacology and potential mechanisms of action of rizatriptan. Cephalalgia 2000;20 suppl 1:2-9.
36. Bigal ME, Sheftell FD, Tepper SJ, Rapoport AM. Migraine and silent infarcts. Are we making the proper decisions? Cephalalgia 2006;26:629-630.
37. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache 2007;47:1436-1442.
38. Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache 1998;38:87-96.